On Friday, OpenAI announced significant changes to its leadership structure. CEO of AGI deployment, Fidji Simo, is taking medical leave due to a relapse of her neuroimmune condition. In Simo's absence, Greg Brockman will lead the product teams.

Simultaneously, the company named Brad Lightcap as a 'special projects' leader and announced that Kate Rouch, chief marketing officer, would be on leave for health reasons following breast cancer treatment. When she returns, her role will be different, with narrower scope.

Simo’s internal note revealed her decision was driven by prioritizing medical tests and treatments over work to maintain her health. This leaves OpenAI in a transitional phase, preparing for new hires such as a chief marketing officer and communications officer.

OpenAI remains undeterred, stating it is well-positioned with a strong leadership team to continue its mission of advancing research, growing user bases, and expanding enterprise use cases. The changes come amid speculation about OpenAI’s potential IPO this year following its latest $122 billion funding round that valued the company at an astounding $852 billion.